LifeMD, Inc. (LFMD) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of LifeMD, Inc. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LFMD
LifeMD, Inc.
$2.76HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.06HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
Total return — LFMD vs PYXS
growth of $100 · dividends reinvested · last 5yLFMD -52.9% (-14.0%/yr)PYXS -83.0% (-29.9%/yr)LFMD compounded faster over this window
LFMD PYXS
LFMD vs PYXS: by the numbers
- •LFMD is the larger company ($133M vs $130M market cap).
- •Both run net losses; LFMD's is the smaller (-10.40% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | LFMD | PYXS |
|---|---|---|
| P/S ratio | 0.65 | 11.80 |
| P/B ratio | 16.73 | 11.38 |
Profitability
| Metric | LFMD | PYXS |
|---|---|---|
| Gross margin | 85.91% | 82.77% |
| Operating margin | -9.35% | -609.18% |
| Net margin | -10.40% | -803.83% |
| ROE | -266.86% | -775.59% |
| ROIC | -143.97% | -314.66% |
Growth (annualized)
| Metric | LFMD | PYXS |
|---|---|---|
| Revenue CAGR (5Y) | 26.00% | N/A |
| Total return CAGR (5Y) | -14.66% | N/A |
Go deeper
Dig into the metrics
LifeMD ROEPyxis Oncology ROELifeMD operating marginPyxis Oncology operating marginLifeMD revenue growthPyxis Oncology revenue growthLifeMD free cash flowPyxis Oncology free cash flow
LifeMD & Pyxis Oncology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.